- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 213/81 - AmidesImides
Patent holdings for IPC class C07D 213/81
Total number of patents in this class: 1342
10-year publication summary
|
121
|
90
|
115
|
80
|
79
|
83
|
60
|
77
|
51
|
46
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Akebia Therapeutics, Inc. | 116 |
42 |
| Corteva Agriscience LLC | 2702 |
39 |
| Novartis AG | 10612 |
32 |
| Syngenta Participations AG | 1730 |
31 |
| Syngenta Crop Protection AG | 6259 |
30 |
| F. Hoffmann-La Roche AG | 7937 |
23 |
| Hoffmann-La Roche Inc. | 3546 |
20 |
| Theravance Biopharma R&D IP, LLC | 453 |
17 |
| Bristol-myers Squibb Company | 4826 |
16 |
| Merck Patent GmbH | 5752 |
14 |
| Purdue Pharma L.P. | 496 |
14 |
| Centre National de La Recherche Scientifique | 10706 |
13 |
| Sumitomo Chemical Company, Limited | 9109 |
12 |
| Vertex Pharmaceuticals Incorporated | 1630 |
11 |
| Bayer Pharma AG | 1048 |
10 |
| Institut Curie | 608 |
10 |
| Boehringer Ingelheim International GmbH | 4636 |
9 |
| Dow AgroSciences LLC | 1214 |
9 |
| Takeda Pharmaceutical Company Limited | 2721 |
9 |
| Abivax | 122 |
9 |
| Other owners | 972 |